SCHEMBL2886354

SCHEMBL2886354

CC(C)(O)c1ccccc1CCC(O)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1.CS(=O)(=O)O

nearest known ligand 0.68

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR known ✓ P00533 1/20 0.63
▸ ADRB2 known ✓ P07550 1/20 0.63
▸ ADRA2A known ✓ P08913 1/20 0.63
▸ CHRM1 known ✓ P11229 1/20 0.63
▸ ADRA2B known ✓ P18089 1/20 0.63
▸ ADRA2C known ✓ P18825 1/20 0.63
▸ SLC6A2 known ✓ P23975 1/20 0.63
▸ DRD3 known ✓ P35462 1/20 0.63
▸ SLC6A3 known ✓ Q01959 1/20 0.63
▸ CYSLTR1 Q9Y271 3/20 0.63
▸ CYP2C8 P10632 2/20 0.63
▸ CYSLTR2 Q9NS75 2/20 0.63
▸ MEN1 O00255 1/20 0.63
▸ RECQL P46063 1/20 0.63
▸ BLM P54132 1/20 0.63
▸ KMT2A Q03164 1/20 0.63
▸ ABCB11 O95342 1/20 0.63
▸ ESR1 P03372 1/20 0.63
▸ NR3C1 P04150 1/20 0.63
▸ FYN P06241 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28786456 1.00 CYSLTR1 (0.63) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL2886360 1.00 CYSLTR1 (0.63) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL990277 0.95 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL201921 0.95 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL29903285 0.95 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL201920 0.95 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL1150080 0.95 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL9926899 0.95 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL30205136 0.95 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
Alcohol SCHEMBL2569564 0.93 CYSLTR1 (0.64) CYSLTR1CYP2C8CYSLTR2MEN1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2142508-A2 PROCESS FOR THE PREPARATION OF SODIUM SALT OF L-(((L(R)-(3-(2-(7-CHLORO-2- QUINOLINYL)-ETHENYL)PHENYL)-3-(2-(L-HYDROXY-L- METHYLETHYL)PHENYL)PROPYL)SULFANYL)METHYL)CYCLOPROPANEACETIC ACID Zaklady Farmaceutyczne "Polpharma" S.A. (PL) 2010-01-13 — — EP claimed
WO-2008136693-A2 PROCESS FOR THE PREPARATION OF SODIUM SALT OF L-(((L(R)-(3-(2-(7-CHLORO-2- QUINOLINYL)-ETHENYL)PHENYL)-3-(2-(L-HYDROXY-L- METHYLETHYL)PHENYL)PROPYL)SULFANYL)METHYL)CYCLOPROPANEACETIC ACID ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) 2008-11-13 — — WO claimed
Send feedback